Have a feature idea you'd love to see implemented? Let us know!

IRTC iRhythm Technologies Inc

Price (delayed)

$73.9

Market cap

$2.31B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.86

Enterprise value

$2.53B

iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based ...

Highlights
The company's gross profit rose by 18% YoY and by 5% QoQ
The revenue has grown by 18% YoY and by 4.3% from the previous quarter
The quick ratio has soared by 194% YoY but it has contracted by 9% from the previous quarter
IRTC's equity has dropped by 67% year-on-year and by 28% since the previous quarter
The company's net income fell by 44% YoY and by 14% QoQ

Key stats

What are the main financial stats of IRTC
Market
Shares outstanding
31.3M
Market cap
$2.31B
Enterprise value
$2.53B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
32.16
Price to sales (P/S)
4.13
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.52
Earnings
Revenue
$560.03M
EBIT
-$139.54M
EBITDA
-$113.9M
Free cash flow
-$72.43M
Per share
EPS
-$4.86
Free cash flow per share
-$2.32
Book value per share
$2.3
Revenue per share
$17.91
TBVPS
$29.07
Balance sheet
Total assets
$909.69M
Total liabilities
$837.92M
Debt
$735.36M
Equity
$71.77M
Working capital
$527.81M
Liquidity
Debt to equity
10.25
Current ratio
6.27
Quick ratio
5.99
Net debt/EBITDA
-1.89
Margins
EBITDA margin
-20.3%
Gross margin
67.8%
Net margin
-26.9%
Operating margin
-26.9%
Efficiency
Return on assets
-19%
Return on equity
-127.9%
Return on invested capital
-16%
Return on capital employed
-17.2%
Return on sales
-24.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IRTC stock price

How has the iRhythm Technologies stock price performed over time
Intraday
0.22%
1 week
-11.43%
1 month
19%
1 year
-11.23%
YTD
-30.96%
QTD
-0.46%

Financial performance

How have iRhythm Technologies's revenue and profit performed over time
Revenue
$560.03M
Gross profit
$379.89M
Operating income
-$150.6M
Net income
-$150.66M
Gross margin
67.8%
Net margin
-26.9%
The company's net income fell by 44% YoY and by 14% QoQ
The operating income has contracted by 41% YoY and by 18% from the previous quarter
The net margin is down by 21% YoY and by 10% from the previous quarter
IRTC's operating margin is down by 19% YoY and by 13% from the previous quarter

Growth

What is iRhythm Technologies's growth rate over time

Valuation

What is iRhythm Technologies stock price valuation
P/E
N/A
P/B
32.16
P/S
4.13
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.52
The EPS has decreased by 41% YoY and by 14% from the previous quarter
IRTC's P/B is 79% above its 5-year quarterly average of 18.0 and 6% above its last 4 quarters average of 30.4
IRTC's equity has dropped by 67% year-on-year and by 28% since the previous quarter
The P/S is 60% below the 5-year quarterly average of 10.3 and 31% below the last 4 quarters average of 6.0
The revenue has grown by 18% YoY and by 4.3% from the previous quarter

Efficiency

How efficient is iRhythm Technologies business performance
iRhythm Technologies's ROE has plunged by 176% YoY and by 50% from the previous quarter
IRTC's return on invested capital is up by 34% year-on-year and by 6% since the previous quarter
The ROA has grown by 21% YoY and by 2.6% from the previous quarter
The ROS has decreased by 17% YoY and by 9% from the previous quarter

Dividends

What is IRTC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IRTC.

Financial health

How did iRhythm Technologies financials performed over time
IRTC's total assets is 9% greater than its total liabilities
The quick ratio has soared by 194% YoY but it has contracted by 9% from the previous quarter
The current ratio has surged by 174% year-on-year but it has declined by 9% since the previous quarter
IRTC's equity has dropped by 67% year-on-year and by 28% since the previous quarter
The debt to equity has grown by 38% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.